FDA inspection
GlaxoSmithKline Biologicals Kft.: FDA inspection ending Feb 13, 2023
FDA inspection 1201815 · No Action Indicated (NAI) · Godollo
Key facts
| Inspection ID | 1201815 |
|---|---|
| Firm | GlaxoSmithKline Biologicals Kft. |
| FEI number | 3008322822 |
| Address | Homoki Nagy Istvan Utca 1 |
| City | Godollo |
| Country | Hungary |
| Fiscal year | 2023 |
| Inspection end date | Feb 13, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data